Skip to main content
Equibles
ABCL logo

ABCL · AbCellera Biologics Inc. · Documents

Track ABCL — free

Use ABCL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ABCL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.62 -0.33 (-2.76%) At close · Nov 12 Play latest call Q3 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$3.80B
Shares
326.62M
Volume · Nov 12 3.16M Avg daily vol (3M) 5.09M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2022
May 10
Quarterly report 10-Q FY2022 Q1, ended Mar 31
Quarterly report for FY2022 Q1
Revenue $316.58M ▲ 56.2% Net income $168.57M ▲ 43.8% Diluted EPS $0.54 ▲ 45.9%
Feb 25
Annual report 10-K FY2021, ended Dec 31
Annual report for FY2021
Revenue $375.2M ▲ 60.9% Net income $153.46M ▲ 29.1% Diluted EPS $0.48 ▲ 6.7%
2021
May 14
Quarterly report 10-Q FY2021 Q1, ended Mar 31
Quarterly report for FY2021 Q1
Revenue $202.74M ▲ 4253.5% Net income $117.22M Diluted EPS $0.37
2020
Showing 101–140 of 140 documents
Key facts CIK 1703057 CUSIP 00288U106 13F (30d) 91 filings 83 filers Visit website Investor relations